Botanix Pharmaceuticals Future Growth
Future criteria checks 6/6
Botanix Pharmaceuticals is forecast to grow earnings and revenue by 99.4% and 77.6% per annum respectively. EPS is expected to grow by 102.1% per annum. Return on equity is forecast to be 54.4% in 3 years.
Key information
99.4%
Earnings growth rate
102.1%
EPS growth rate
| Pharmaceuticals earnings growth | 23.7% |
| Revenue growth rate | 77.6% |
| Future return on equity | 54.4% |
| Analyst coverage | Low |
| Last updated | 11 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 201 | 110 | 100 | 95 | 1 |
| 6/30/2026 | 105 | 34 | 20 | 18 | 1 |
| 6/30/2025 | 36 | 4 | -7 | -7 | 1 |
| 6/30/2024 | 2 | -14 | -26 | -8 | N/A |
| 3/31/2024 | 1 | -12 | -26 | -9 | N/A |
| 12/31/2023 | 0 | -10 | -27 | -10 | N/A |
| 9/30/2023 | 2 | -10 | -23 | -11 | N/A |
| 6/30/2023 | 4 | -9 | -19 | -12 | N/A |
| 3/31/2023 | 5 | -10 | -20 | -12 | N/A |
| 12/31/2022 | 6 | -11 | -20 | -12 | N/A |
| 9/30/2022 | 5 | -12 | -17 | -12 | N/A |
| 6/30/2022 | 3 | -13 | -14 | -11 | N/A |
| 3/31/2022 | 1 | -12 | -8 | -7 | N/A |
| 12/31/2021 | 0 | -11 | -2 | -2 | N/A |
| 9/30/2021 | 3 | -7 | -3 | -3 | N/A |
| 6/30/2021 | 7 | -3 | -3 | -3 | N/A |
| 3/31/2021 | 7 | -6 | -6 | -6 | N/A |
| 12/31/2020 | 7 | -9 | -8 | -8 | N/A |
| 9/30/2020 | 7 | -13 | -13 | -13 | N/A |
| 6/30/2020 | 8 | -17 | -17 | -17 | N/A |
| 3/31/2020 | 8 | -18 | -21 | -21 | N/A |
| 12/31/2019 | 8 | -20 | -24 | -24 | N/A |
| 9/30/2019 | 6 | -18 | -19 | -19 | N/A |
| 6/30/2019 | 5 | -17 | -13 | -13 | N/A |
| 3/31/2019 | 5 | -15 | -12 | -12 | N/A |
| 12/31/2018 | 5 | -13 | -10 | -10 | N/A |
| 9/30/2018 | 3 | -12 | -10 | -10 | N/A |
| 6/30/2018 | 2 | -11 | -10 | -10 | N/A |
| 3/31/2018 | 2 | -8 | N/A | -8 | N/A |
| 12/31/2017 | 2 | -6 | N/A | -7 | N/A |
| 9/30/2017 | 1 | -5 | N/A | -6 | N/A |
| 6/30/2017 | N/A | -5 | N/A | -5 | N/A |
| 12/31/2016 | N/A | -3 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BXPH.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: BXPH.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BXPH.F is expected to become profitable in the next 3 years.
Revenue vs Market: BXPH.F's revenue (77.6% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: BXPH.F's revenue (77.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BXPH.F's Return on Equity is forecast to be very high in 3 years time (54.4%).